Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Angiopoietin-like Protein 8/Betatrophin Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB8548
This item is not returnable.
View return policy
Description
Angiopoietin-like protein 8/Betatrophin Monoclonal specifically detects Angiopoietin-like protein 8/Betatrophin in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry.Specifications
Angiopoietin-like protein 8/Betatrophin | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. with No Preservative | |
Angiopoietin like Protein 8, ANGPTL8, Betatrophin, C19orf80, chromosome 19 open reading frame 80, Gm6484, hepatocellular carcinoma-associated gene TD26, hepatocellular carcinoma-associated protein TD26, Lipasin, PRO1185, PVPA599, RIFL, TD26, UNQ599 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
55908 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Western Blot, Immunohistochemistry, Immunocytochemistry | |
910248 | |
Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Immunocytochemistry 8-25 ug/mL | |
Q6UXH0 | |
ANGPTL8 | |
Human Angiopoietin-like Protein 8/Betatrophin synthetic peptide with sequences corresponding to the N-term region Accession # Q6UXH0 | |
100 μg | |
Primary | |
Detects human Angiopoietin-like Protein 8/Betatrophin in direct ELISA and Western Blots. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction